Because the cytotoxicity of chemotherapeutic agents is attributed largely to apoptosis, the activation of NF-κB can effectively suppress the apoptotic potential of chemotherapeutic agents, thus contributing a crucial obstacle to effective treatment of pancreatic cancer. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.